Sarepta will stop shipping its Duchenne muscular dystrophy gene therapy Elevidys following ongoing discussions with the FDA over safety labeling.  The drugmaker said the pause, effective July 22, will allow time to respond to FDA inquiries and complete the agency’s…

Here are nine new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. 

A combination of two cancer drugs may provide a pathway to treat Alzheimer’s, according to a study published July 21 in Cell.  Researchers from the University of California San Francisco developed and applied a computational drug repurposing algorithm to 1,300…

Ninety-three percent of hospitals responding to a recent survey conducted by 340B Health said they would struggle to maintain current levels of uncompensated care in the wake of drugmakers’ proposed rebate plan changes with respect to the federal 340B pricing…

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and training: immunotherapy.  To better navigate the complex and strategic considerations presented by immunotherapy, healthcare leaders…

With hundreds of drug shortages persisting across the U.S., pharmacy leaders are adopting more coordinated strategies to manage supply disruptions and mitigate financial losses. These include expanding on-hand inventory for critical injectable medications, centralizing supply chain operations and embedding clinical…

Sarepta Therapeutics said it will continue shipping its gene therapy Elevidys for Duchenne muscular dystrophy patients despite an FDA request to pause distribution following multiple patient deaths.  The FDA’s request July 18 came after Sarepta confirmed the death of a…

An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.  The report, requested by Democratic lawmakers, examined a hypothetical…

IV robotics and workflow preparation technology is critical to the advancement of patient safety and accuracy in IV compounding. But while the need is widely recognized, barriers to adoption – including tight budgets, bandwidth constraints, and lack of regulations or…

AHA has filed a legal brief in support of a Colorado law that ensures 340B discounted drugs can be delivered to contract pharmacies.  The brief comes amid a lawsuit brought by drugmaker AbbVie, which argues that Colorado’s law is preempted…